Ulla Feldt-Rasmussen
Clinical Professor
Department of Clinical Medicine
Blegdamsvej 9, 2100 København Ø
1 - 4 out of 4Page size: 25
- Published
Abnormal bone collagen morphology and decreased bone strength in growth hormone-deficient rats.
Lange, M., Qvortrup, Klaus, Svendsen, Ole Lander, Flyvbjerg, A., Nowak, J., Petersen, M. M., Ølgaard, Klaus & Feldt-Rasmussen, Ulla, 2004, In: Bone. 35, 1, p. 178-85 7 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Effect of growth hormone replacement therapy on pituitary hormone secretion and hormone replacement therapies in GHD adults
Hubina, E., Mersebach, H., Rasmussen, A. K., Juul, Anders, Sneppen, S. B., Góth, M. I. & Feldt-Rasmussen, Ulla, 2004, In: Hormone Research. 61, 5, p. 211-7 7 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
The insulin-like growth axis in patients with autoimmune thyrotoxicosis: effect of antithyroid drug treatment
Zimmermann-Belsing, T., Juul, Anders, Juul Holst, J. & Feldt-Rasmussen, Ulla, 2004, In: Growth Hormone & I G F Research. 14, 3, p. 235-44 10 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Thyrotropin-releasing hormone stimulation test in patients with pituitary pathology.
pxw866, P., Hartoft-Nielsen, M., Rasmussen, Å. K., Zimmermann-Belsing, T. & Feldt-Rasmussen, Ulla, 2004, In: Hormone Research. 61(2):53-7Research output: Contribution to journal › Journal article › Research › peer-review
ID: 916030
Most downloads
-
11644
downloads
Recent advances in understanding autoimmune thyroid disease: the tallest tree in the forest of polyautoimmunity
Research output: Contribution to journal › Review › Research › peer-review
Published -
2167
downloads
The chronic autoimmune thyroiditis quality of life selenium trial (CATALYST): study protocol for a randomized controlled trial
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
283
downloads
Oral pharmacological chaperone migalastat compared with enzyme replacement therapy in Fabry disease: 18-month results from the randomised phase III ATTRACT study
Research output: Contribution to journal › Journal article › Research › peer-review
Published